Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunization

eLife

Volumn 2015, Issue 4, 2015, Pages

  Nahrendorf, Wiebke ^a,b,c   Spence, Philip J ^a,c   Tumwine, Irene ^a   Lévy, Prisca ^a   Jarra, William ^a   Sauerwein, Robert W ^b   Langhorne, Jean ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; SPOROZOITE VACCINE; ANTIMALARIAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOPROPHYLAXIS; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INFECTION CONTROL; INFECTION RISK; MOUSE; NONHUMAN; PARASITE IMMUNITY; PARASITE TRANSMISSION; PARASITE VIRULENCE; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI INFECTION; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; ERYTHROCYTE; HOST PARASITE INTERACTION; HUMAN; IMMUNOLOGY; INSECT VECTOR; MALARIA; MOSQUITO; PARASITEMIA; PARASITOLOGY; PHYSIOLOGY; PROCEDURES; SPOROZOITE; TIME FACTOR;

PLASMODIUM CHABAUDI;

ANIMALS; ANTIMALARIALS; CHEMOPREVENTION; CHLOROQUINE; CULICIDAE; ERYTHROCYTES; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNIZATION; INSECT VECTORS; MALARIA; MICE, INBRED C57BL; PARASITEMIA; PLASMODIUM CHABAUDI; SPOROZOITES; TIME FACTORS;

EID: 84925061986     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.05165     Document Type: Article

References (60)

1. Mutapi F, Billingsley PF, Secor WE: Infection and treatment immunizations for successful parasite vaccines. Trends Parasitol 2013, 29: 135-141. doi: 10. 1016/j. pt. 2013. 01. 003.
2. Fox JP: Modes of action of poliovirus vaccines and relation to resulting immunity. Rev Infect Dis 1984, 6 Suppl 2: S352-355. doi: 10. 1093/clinids/6. Supplement_2. S352.
3. Mielcarek N, Debrie AS, Raze D, Bertout J, Rouaret C, Younes AB, Creusy C, Engle J, Goldman WE, Locht C: Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2006, 2: e65. doi: 10. 1371/journal. ppat. 0020065.
4. Delany I, Rappuoli R, De Gregorio E: Vaccines for the 21st century. EMBO Mol Med2014. doi: 10. 1002/emmm. 201403876.
5. Goncalves BP, Huang CY, Morrison R, Holte S, Kabyemela E, Prevots DR, Fried M, Duffy PE: Parasite burden and severity of malaria in Tanzanian children. N Engl J Med 2014, 370: 1799-1808. doi: 10. 1056/NEJMoa1303944.
6. Okell LC, Ghani AC, Lyons E, Drakeley CJ: Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and metaanalysis. J Infect Dis 2009, 200: 1509-1517. doi: 10. 1086/644781.
7. Kappe SH, Vaughan AM, Boddey JA, Cowman AF: That was then but this is now: malaria research in the time of an eradication agenda. Science 2010, 328: 862866. doi: 10. 1126/science. 1184785.
8. Nussenzweig RS, Vanderberg J, Most H, Orton C: Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 1967, 216: 160-162. doi: 10. 1038/216160a0.
9. Mueller AK, Labaied M, Kappe SH, Matuschewski K: Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005, 433: 164-167. doi: 10. 1038/nature03188.
10. Clyde DF, Most H, McCarthy VC, Vanderberg JP: Immunization of man against sporozoite-induced falciparum malaria. Am J Med Sci 1973, 266: 169-177.
11. Seder RA, Chang LJ, Erama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, et al: Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 2013, 341: 1359-1365. doi: 10. 1126/science. 1241800.
12. Bejon P, Cook J, Bergmann-Leitner E, Olotu A, Lusingu J, Mwacharo J, Vekemans J, Njuguna P, Leach A, Lievens M, et al: Effect of the pre-erythrocytic candidate malaria vaccine RTS, S/AS01E on blood stage immunity in young children. J Infect Dis 2011, 204: 9-18. doi: 10. 1093/infdis/jir222.
13. Goodman AL, Draper SJ: Blood-stage malaria vaccines-recent progress and future challenges. Ann Trop Med Parasitol 2010, 104: 189-211. doi: 10. 1179/136485910X12647085215534.
14. Ellis RD, Sagara I, Doumbo O, Wu Y: Blood stage vaccines for Plasmodium falciparum: current status and the way forward. Hum Vaccin 2010, 6: 627-634. doi: 10. 4161/hv. 6. 8. 11446.
15. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, et al: Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 2009, 361: 468-477. doi: 10. 1056/NEJMoa0805832.
16. Bijker EM, Teirlinck AC, Schats R, van Gemert GJ, van de Vegte-Bolmer M, van Lieshout L, IntHout J, Hermsen CC, Scholzen A, Visser LG, Sauerwein RW: Cytotoxic Markers Associate with Protection against Malaria in Human Volunteers Immunized with Plasmodium falciparum Sporozoites. J Infect Dis 2014. doi: 10. 1093/infdis/jiu293.
17. Bijker EM, Bastiaens GJ, Teirlinck AC, van Gemert GJ, Graumans W, van de Vegte-Bolmer M, Siebelink-Stoter R, Arens T, Teelen K, Nahrendorf W, et al: Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc Natl Acad Sci USA 2013, 110: 7862-7867. doi: 10. 1073/pnas. 1220360110.
18. Stephens R, Culleton RL, Lamb TJ: The contribution of Plasmodium chabaudi to our understanding of malaria. Trends Parasitol 2012, 28: 73-82. doi: 10. 1016/j. pt. 2011. 10. 006.
19. Spence PJ, Jarra W, Levy P, Nahrendorf W, Langhorne J: Mosquito transmission of the rodent malaria parasite Plasmodium chabaudi. Malar J 2012, 11: 407. doi: 10. 1186/1475-2875-11-407.
20. Mackinnon MJ, Read AF: Selection for high and low virulence in the malaria parasite Plasmodium chabaudi. Proc Biol Sci 1999, 266: 741-748. doi: 10. 1098/rspb. 1999. 0699.
21. Otto TD, Bohme U, Jackson AP, Hunt M, Franke-Fayard B, Hoeijmakers WA, Religa AA, Robertson L, Sanders M, Ogun SA, et al: A comprehensive evaluation of rodent malaria parasite genomes and gene expression. BMC Biol 2014, 12: 86. doi: 10. 1186/S12915-014-0086-0.
22. Beaudoin RL, Strome CP, Mitchell F, Tubergen TA: Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Exp Parasitol 1977, 42: 1-5. doi: 10. 1016/0014-4894(77)90054-6.
23. Golenser J, Heeren J, Verhave JP, Kaay HJ, Meuwissen JH: Crossreactivity with sporozoites, exoerythrocytic forms and blood schizonts of Plasmodium berghei in indirect fluorescent antibody tests with sera of rats immunized with sporozoites or infected blood. Clin Exp Immunol 1977, 29: 43-51.
24. Orjih AU, Cochrane AH, Nussenzweig RS: Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei. Trans R Soc Trop Med Hyg 1982, 76: 57-61. doi: 10. 1016/0035-9203(82) 90019-0.
25. Nganou-Makamdop K, van Gemert GJ, Arens T, Hermsen CC, Sauerwein RW: Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNgamma responses of hepatic CD8+ memory T cells. PLoS One 2012, 7: e36508. doi: 10. 1371/journal. pone. 0036508.
26. Friesen J, Matuschewski K: Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite. Vaccine 2011, 29: 7002-7008. doi: 10. 1016/j. vaccine. 2011. 07. 034.
27. Belnoue E, Costa FT, Frankenberg T, Vigario AM, Voza T, Leroy N, Rodrigues MM, Landau I, Snounou G, Renia L: Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 2004, 172: 2487-2495. doi: 10. 4049/jimmunol. 172. 4. 2487.
28. Peng X, Keitany GJ, Vignali M, Chen L, Gibson C, Choi K, Huang F, Wang R: Artesunate versus Chloroquine Infection-Treatment-Vaccination Defines Stage-Specific Immune Responses Associated with Prolonged Sterile Protection against Both Pre-erythrocytic and Erythrocytic Plasmodium yoelii Infection. J Immunol2014. doi: 10. 4049/jimmunol. 1400296.
29. Inoue M, Tang J, Miyakoda M, Kaneko O, Yui K, Culleton R: The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development. Int J Parasitol 2012, 42: 859-870. doi: 10. 1016/j. ijpara. 2012. 07. 001.
30. Doll KL, Butler NS, Harty JT: CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii. Vaccine 2014, 32: 483-491. doi: 10. 1016/j. vaccine. 2013. 11. 058.
31. Lewis MD, Pfeil J, Heiss K, Mueller AK: CD8(+) T cells mediate robust stage-specific immunity to P. berghei under chemoprophylaxis and this protective environment is not downregulated by the presence of blood-stage infection. PLoS One 2014, 9: e88117. doi: 10. 1371/journal. pone. 0088117.
32. Ponnudurai T, Lensen AH, van Gemert GJ, Bolmer MG, Meuwissen JH: Feeding behaviour and sporozoite ejection by infected Anopheles stephensi. Trans R Soc Trop Med Hyg 1991, 85: 175-180. doi: 10. 1016/0035-9203(91)90012-N.
33. Beier JC, Davis JR, Vaughan JA, Noden BH, Beier MS: Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi. Am J Trop Med Hyg 1991, 44: 564-570.
34. Medica DL, Sinnis P: Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes. Infect Immun 2005, 73: 43634369. doi: 10. 1128/IAI. 73. 7. 4363-4369. 2005.
35. Suhrbier A, Winger LA, Castellano E, Sinden RE: Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells. Infect Immun 1990, 58: 2834-2839.
36. Spence PJ, Jarra W, Levy P, Reid AJ, Chappell L, Brugat T, Sanders M, Berriman M, Langhorne J: Vector transmission regulates immune control of Plasmodium virulence. Nature 2013, 498: 228-231. doi: 10. 1038/nature12231.
37. Belnoue E, Voza T, Costa FT, Gruner AC, Mauduit M, Rosa DS, Depinay N, Kayibanda M, Vigario AM, Mazier D, et al: Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J Immunol 2008, 181: 8552-8558. doi: 10. 4049/jimmunol. 181. 12. 8552.
38. Legorreta-Herrera M, Ventura-Ayala ML, Licona-Chavez RN, Soto-Cruz I, Hernandez-Clemente FF: Early treatment during a primary malaria infection modifies the development of cross immunity. Parasite Immunol 2004, 26: 7-17. doi: 10. 1111/j. 0141-9838. 2004. 00677. x.
39. Elliott SR, Kuns RD, Good MF: Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria. Infect Immun 2005, 73: 2478-2485. doi: 10. 1128/IAI. 73. 4. 2478-2485. 2005.
40. Guilbride DL, Guilbride PD, Gawlinski P: Malaria's deadly secret: a skin stage. Trends Parasitol2012, 28: 142-150. doi: 10. 1016/j. pt. 2012. 01. 002.
41. Nganou-Makamdop K, Ploemen I, Behet M, Van Gemert GJ, Hermsen C, Roestenberg M, Sauerwein RW: Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization. Parasite Immunol 2012, 34: 562-569. doi: 10. 1111/pim. 12000. x.
42. Khan ZM, Vanderberg JP: Role of host cellular response in differential susceptibility of nonimmunized BALB/c mice to Plasmodium berghei and Plasmodium yoelii sporozoites. Infect Immun 1991, 59: 2529-2534.
43. White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM: Malaria. Lancet 2014, 383: 723-735. doi: 10. 1016/S0140-6736(13)60024-0.
44. Tran TM, Li S, Doumbo S, Doumtabe D, Huang CY, Dia S, Bathily A, Sangala J, Kone Y, Traore A, et al: An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin Infect Dis 2013, 57: 40-47. doi: 10. 1093/cid/cit174.
45. Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, Richie TL, Baldi P, Feigner PL, Doolan DL: Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol Cell Proteomics 2011, 10: M111 007948. doi: 10. 1074/mcp. M111. 007948.
46. Roestenberg M, O'Hara GA, Duncan CJ, Epstein JE, Edwards NJ, Scholzen A, van der Ven AJ, Hermsen CC, Hill AV, Sauerwein RW: Comparison of clinical and parasitological data from controlled human malaria infection trials. PLoS One 2012, 7: e38434. doi: 10. 1371/journal. pone. 0038434.
47. Jarra W, Brown KN: Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi and P. berghei in CBA/Ca mice. I. The effectiveness and inter-and intra-species specificity of immunity induced by infection. Parasite Immunol 1985, 7: 595-606. doi: 10. 1111/j. 1365-3024. 1985. tb00103. x.
48. Pombo DJ, Lawrence G, Hirunpetcharat C, Rzepczyk C, Bryden M, Cloonan N, Anderson K, Mahakunkijcharoen Y, Martin LB, Wilson D, et al: Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 2002, 360: 610-617. doi: 10. 1016/S0140-6736(02)09784-2.
49. Collins WE, Jeffery GM: A retrospective examination of secondary sporozoite-and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am J Trop Med Hyg 1999, 61: 20-35. doi: 10. 4269/tropmed. 1999. 61-020.
50. Bull PC, Lowe BS, Kortok M, Molyreu CS, Newbold Cl, Marsh K: Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med 1998, 4: 358-360. doi: 10. 1038/nm0398-358.
51. McLean SA, Pearson CD, Phillips RS: Plasmodium chabaudi: antigenic variation during recrudescent parasitaemias in mice. Exp Parasitol 1982, 54: 296-302. doi: 10. 1016/0014-4894(82)90038-8.
52. Good MF, Reiman JM, Rodriguez IB, Ito K, Yanow SK, El-Deeb IM, Batzloff MR, Stanisic Dl, Engwerda C, Spithill T, et al: Cross-species malaria immunity induced by chemically attenuated parasites. J Clin Invest 2013. doi: 10. 1172/JCI66634.
53. Aly AS, Downie MJ, Mamoun CB, Kappe SH: Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice. Cell Microbiol 2010, 12: 930-938. doi: 10. 1111/j. 1462-5822. 2010. 01441. x.
54. Ting LM, Gissot M, Coppi A, Sinnis P, Kim K: Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity. Nat Med 2008, 14: 954-958. doi: 10. 1038/nm. 1867.
55. Lamb TJ, Langhorne J: The severity of malarial anaemia in Plasmodium chabaudi infections of BALB/c mice is determined independently of the number ofcirculating parasites. Malar J 2008, 7: 68. doi: 10. 1186/1475-2875-7-68.
56. Purcell LA, Wong KA, Yanow SK, Lee M, Spithill TW, Rodriguez A: Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. Vaccine 2008, 26: 4880-4884. doi: 10. 1016/j. vaccine. 2008. 07. 017.
57. Lawton J, Brugat T, Yan YX, Reid AJ, Bohme U, Otto TD, Pain A, Jackson A, Berriman M, Cunningham D, et al: Characterization and gene expression analysis of the cir multi-gene family of Plasmodium chabaudi chabaudi (AS). BMC Genomics 2012, 13: 125. doi: 10. 1186/1471-2164-13-125.
58. Tarun AS, Peng X, Dumpit RF, Ogata Y, Silva-Rivera H, Camargo N, Daly TM, Bergman LW, Kappe SH: A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci U S A 2008, 105: 305-310. doi: 10. 1073/pnas. 0710780104.
59. Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, Harty JT: Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 2011, 9: 451-462. doi: 10. 1016/j. chom. 2011. 05. 008.
60. Chomczynski P, Sacchi N: The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 2006, 1: 581-585. doi: 10. 1006/abio. 1987. 9999.